New Med to Manage Tourette Syndrome Shows Promise in Phase III Clinical Trial
PRNewsWire
·
2026-05-26
·
via The Tech Buzz - Press Releases
Emalex Biosciences to use data from research led by Cincinnati Children's to seek FDA approval for ecopipam,…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。